Logo for Algernon Pharmaceuticals Inc.
AGN
-10.00%

Algernon Pharmaceuticals Inc.

Associated Securities:
Status
ActiveT2
Issued & Outstanding27,300,779
Reserved for Issuance19,387,036
CurrencyCAD
CSE IndexNo

Quote

Last Price0.09-0.01 (-10.00%)
Volume41,320
Change-0.01
Bid Size11,500
Bid Price0.085
Ask Price0.09
Ask Size10,000
Prev Close0.10
Open0.095
Day High0.095
Day Low0.09
52 Week High0.165
52 Week Low0.06

Algernon Pharmaceuticals Inc.

Charts by TradingView

Depth Display

Recent Trades

About

Algernon Pharmaceuticals Inc.

Listing Date
February 01, 2016

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.